Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Saxenda (Liraglutide): Bridging the Gap Saxenda, another GLP-1 receptor agonist, has gained approval for chronic weight management
Some people report that levocarnitine-containing injections produce slightly more injection site irritation than plain tirzepatide
: ( ) , -
SURMOUNT-1 trial data showed mean weight reductions of 15.0% (5mg), 19.5% (10mg), and 20.9% (15mg) at 72 weeks, compared to 3.1% with placebo
Accountability and Support: When you hit a plateau or have a tough week, an online chatbot cant offer the same support as our local team
Clinical trials have demonstrated significant weight loss and glycaemic control with tirzepatide, with the SURMOUNT and SURPASS trial programmes providing robust evidence for its efficacy
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
